Tag: #Global Trends

The psychedelic medicine sector experienced a broad market rally on February 17, 2026, following breakthrough data from Compass Pathways. The... Read more

The U.S. Food and Drug Administration (FDA) has reversed its earlier stance and will now proceed with the regulatory review... Read more

Eli Lilly has announced the success of its Phase 3b Together-PsO trial, demonstrating that combining the obesity medication Zepbound with... Read more

Less than six months after its inaugural approval, Novartis’ oral BTK inhibitor Rhapsido (remibrutinib) is positioning itself to become the... Read more

Pharmaceutical giant Eli Lilly has officially teamed up with the U.S. Olympic & Paralympic Committee (USOPC) to launch and expand... Read more

As part of its overall $55 billion U.S. investment plan, Johnson & Johnson (J&J) has announced the construction of a... Read more

President Donald Trump is pushing forward with his Most Favored Nation (MFN) plan to reduce prescription drug costs, but the... Read more

The European Commission has officially granted marketing authorization for Gotenfia, a golimumab biosimilar developed through the partnership between Bio-Thera and... Read more

French pharmaceutical giant Sanofi has announced a major leadership transition, with Belén Garijo set to take over as CEO, replacing... Read more